Baxter SA-NV is a finished-dose manufacturer based in Saudi Arabia. It appears in 664 regulatory filings across 20 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, FAMHP (BE) and SWISSMEDIC (CH). Its GMP standing is certified by EMA and SFDA (Saudi Arabia). Customs aggregates show $195K of exports covering 5 molecules to 2 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Dammam, United Arab Emirates | Not on file |
| Lessines, Belgium | Not on file |
| Opfikon, Switzerland | Not on file |
| Riyadh, Saudi Arabia | Not on file |
| Jeddah, Saudi Arabia | Not on file |
| Al Dammam, Saudi Arabia | Not on file |
1 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| Health Canada | 300 | None |
| FAMHP (BE) | 151 | None |
| SWISSMEDIC (CH) | 48 | None |
| ANSM (FR) | 48 | None |
| SFDA (Saudi Arabia) | 35 | 1 |
| INHRR (VE) | 24 | None |
| EMA | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $195K | 2 |
| 2024 | Not reported | $341K | 2 |
| 2023 | Not reported | $647K | 4 |
| 2022 | Not reported | $644K | 2 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Baxter SA-NV comes back tiered against every other supplier able to file there.
Start for free